Fulgent Genetics, Inc. PP&E Disclosure
Major classes of fixed assets consisted of the following:
|
Useful Lives |
December 31, 2025 |
|
|
December 31, 2024 |
|
||
|
|
(in thousands) |
|
|||||
Medical lab equipment |
5 months to 13 Years |
$ |
60,691 |
|
|
$ |
57,541 |
|
Building improvements |
6 months to 39 Years |
|
33,198 |
|
|
|
27,924 |
|
Building |
25 to 39 Years |
|
21,689 |
|
|
|
21,689 |
|
Computer hardware |
1 to 5 Years |
|
8,640 |
|
|
|
7,328 |
|
Aircraft |
7 Years |
|
6,400 |
|
|
|
6,400 |
|
Computer software |
1 to 10 Years |
|
6,300 |
|
|
|
7,214 |
|
Leasehold improvements |
|
4,473 |
|
|
|
3,323 |
|
|
Furniture and fixtures |
1 to 11 Years |
|
4,128 |
|
|
|
4,109 |
|
Land improvements |
5 to 15 Years |
|
938 |
|
|
|
904 |
|
Automobile |
3 to 8 Years |
|
628 |
|
|
|
581 |
|
General equipment |
5 Years |
|
226 |
|
|
|
108 |
|
Land |
|
|
17,347 |
|
|
|
17,347 |
|
Assets not yet placed in service |
|
|
5,836 |
|
|
|
2,792 |
|
Total |
|
|
170,494 |
|
|
|
157,260 |
|
Less: Accumulated depreciation |
|
|
(57,945 |
) |
|
|
(51,711 |
) |
Fixed assets, net |
|
$ |
112,549 |
|
|
$ |
105,549 |
|
Want the next Fulgent Genetics, Inc. pp&e disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Fulgent Genetics, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Mar 8, 2021 | |
| 2019 | Mar 13, 2020 | |
| 2017 | Mar 20, 2018 | |
About PP&E Disclosures
The PP&E disclosure details a company's physical asset base — land, buildings, machinery, and equipment — along with the depreciation methods and useful life assumptions that determine how these costs flow through the income statement. Capitalization policy thresholds reveal management's judgment on the boundary between expense and asset, directly affecting both reported earnings and asset values.
Key signals: changes in estimated useful lives or depreciation methods can materially shift reported earnings without any operational change. Compare capital expenditures against depreciation expense — when capex consistently trails depreciation, the asset base may be aging and underinvested. Watch for large asset impairments or write-downs that signal overvalued carrying amounts. Asset retirement obligations reveal future environmental or decommissioning costs that are often underappreciated. Compare PP&E intensity (PP&E-to-revenue) against industry peers to assess capital efficiency and competitive positioning.